Skin marking for indicating subdermal chip
Claim Score by NHIP
Abstract
The presence of a device that is implanted under the skin of a subject and that stores information that can be read by an external device is indicated by an externally visible marking on the skin of the subject.

Term
Term ended
Projected expiry passed 16 April 2022, 4.4 years ago.
- Priority and filed
- Published
- Projected expiry
- Today
6 claims: 2 independent, 4 dependent
- 1Broadest claimClaim Score 96, very broad(NHIP)A combination comprising a device that is implanted under the skin of a subject and that stores information that can be read by an external device, and a marking on or in the skin of the subject that is externally visible and that designates the presence of the implanted device.
- 5A method of indicating the presence of a device that is implanted under the skin of a subject and that stores information that can be read by an external device, the method comprising the steps of providing a subject having a device that is implanted under the skin of a subject and that stores information that can be read by an external device, and creating an externally visible marking on or in the skin of the subject to indicate the presence of the implanted device.
Independent claims2
11 paragraphs in 3 sections, as filed
BACKGROUND OF THE INVENTION
[0001] The present invention relates to a skin marking to indicate the presence of a subdermal chip.
[0002] In recent years, miniaturized chips have been developed that can be implanted under the skin of a subject and that can hold detailed identification data, including complete medical records of the subject. Typically, such chips, once they are implanted, are dormant until activated by an external scanner, at which time they emit a radio frequency signal that can be picked up by the scanner. In operation, an implanted chip may provide hospitals and emergency workers with critical medical information on a subject. For example, if a subject is brought into an emergency room unconscious, or if a subject is an Alzheimer's patient who wanders, the chip may provide everything from basic identification and medical insurance data to vital information about allergies and medications. Moreover, chips may be implanted in pets to provide identification data.
[0003] A problem that may arise with implanted chips is that until implanted subdermal chips become more widely used, persons, such as emergency room workers, who could use the information contained in an implanted chip, may be unaware of the chip's presence and may not think to expose the subject to a scanner to read the information. If a subject is unconscious, an Alzheimer's patient or an amnesiac or a nonhuman, the subject will not be able to notify others of the presence of the chip. As smaller chips are developed, it is less likely that there will be scars or other indications that a chip has been implanted. Accordingly, there is a great need for a designation to let others know that a subject has an implanted subdermal chip.
BRIEF DESCRIPTION OF THE DRAWINGS
[0004]FIG. 1 is a schematic cross-sectional view of skin and subdermal regions of a subject having an implanted chip and an external marking in accordance with an embodiment of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0005] As shown schematically in FIG. 1, a chip <b>10</b> is implanted under surface <b>12</b> of the skin of a subject. In accordance with the present invention, the surface of the skin includes an external marking <b>14</b> that indicates the presence of the subdermal chip.
[0006] The subdermal chip in accordance with the present invention can by any device implanted under the skin of a subject to store information in a form that can be read by an external device such as a scanner. For example, an implantable device has been developed by Applied Digital Solutions and marketed under the name of VeriChip. (See, for example, the Applied Digital Solutions Web site at www.adsx.com.) The Verichip device is about the size of a grain of rice and is implanted by way of a needle-like instrument in an outpatient procedure. The chip is activated by an external scanner and emits a radio frequency signal containing a verification number. The verification number is sent to a data storage site to obtain detailed information on the subject. It is anticipated that as the technology develops, such devices will be made even smaller and will contain more detailed information that can be immediately accessed.
[0007] The external marking in accordance with the present invention can be any permanent or removable mark imprinted on the surface of the skin of the subject or embedded in the dermal layer of the skin so that it is externally visible or detectable. Preferably, the external marking is imprinted or embedded in the skin so that it is not washed or scraped off during normal activities of the subject. For example, the external marking may be in the form of a tattoo, that is, in the form of particles or droplets, such as, for example, ink particles or ink droplets, embedded in the dermal layer of the skin of the subject.
[0008] The external marking may range from a simple designation, such as a circle or arrow indicating the presence of the chip, to a more sophisticated written message conveying, for example, information about the make and model of the implanted chip and about the conditions for activating and reading the chip. Standardized numerical or symbolic designations could be developed to be recognized by medical or emergency personnel as a shorthand for conveying technical information about the chip. Preferably, in the development of standardized numerical or symbolic designation, figures that are commonly used in decorative tattoos would be avoided in order to distinguish subjects having decorative tattoos from subjects having external markings in accordance with the present invention.
[0009] The process of marking the skin of the subject may be carried out at or about the same time as the implantation of the subdermal device, or may be carried out at a different time, before or after the implantation.
[0010] Preferably, the external marking is on the surface of the skin right above or immediately adjacent to the subdermal device, so that the location of the subdermal device can be immediately determined. However, if a subdermal device is of such a type that it is not necessary for the external scanner to be placed immediately above the subdermal device, a precise indication of the location of the subdermal device may not be necessary. In such a case, the external marking may be placed anywhere that it may be reasonably noticeable by emergency or medical personnel.
[0011] Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
Contents3
2 sheets
Sheet 1 Sheet 2
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US8639321B2 | Cited by | United States of America | Applicant |
| US2007071807A1 | Cited by | United States of America | Pre-grant |
| US2006264774A1 | Cited by | United States of America | Pre-grant |
| US2012221036A1 | Cited by | United States of America | Pre-grant |
| US9113956B2 | Cited by | United States of America | Search report |
| US2008208236A1 | Cited by | United States of America | Pre-grant |
| US2009240188A1 | Cited by | United States of America | Pre-grant |
| US8401633B2 | Cited by | United States of America | Applicant |
| EP2551789A1 | Cited by | European Patent Office (EPO) | Search report |
| US8369942B2 | Cited by | United States of America | Search report |
| US2009240241A1 | Cited by | United States of America | Pre-grant |
| US2009240189A1 | Cited by | United States of America | Pre-grant |
| US2007093788A1 | Cited by | United States of America | Pre-grant |
| US2008077076A1 | Cited by | United States of America | Pre-grant |
| US2007088331A1 | Cited by | United States of America | Pre-grant |
| US8366686B2 | Cited by | United States of America | Search report |
| US9271805B2 | Cited by | United States of America | Applicant |
| US2009240231A1 | Cited by | United States of America | Pre-grant |
| WO2013014101A1 | Cited by | World Intellectual Property Organization (WIPO) | Search report |
| CN103765435A | Cited by | China | Search report |
| US5935078A | Cites | United States of America | Pre-grant |
| US6173715B1 | Cites | United States of America | Pre-grant |
| US6216030B1 | Cites | United States of America | Pre-grant |
| US6287293B1 | Cites | United States of America | Pre-grant |
| US6296610B1 | Cites | United States of America | Pre-grant |
| US6363940B1 | Cites | United States of America | Pre-grant |
| US6464687B1 | Cites | United States of America | Pre-grant |
| US6483929B1 | Cites | United States of America | Pre-grant |
2 members in 1 office
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 12229902 | United States of America | A | |
| US20020122299 | – | – | – |
Members2
| Document | Office | Kind | |
|---|---|---|---|
| US2003195523A1 | United States of America | A1 | |
| US2007066891A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Information on status: application discontinuationEXPRESSLY ABANDONED -- DURING EXAMINATIONSTCB | STCB |
Numbers
- Publication, DOCDB
- 2003195523
- Publication, EPODOC
- US2003195523
- Application
- 10122299
- Application, DOCDB
- 12229902
- Application, EPODOC
- US20020122299
Titles
- English
- Skin marking for indicating subdermal chip
Classification
- CPC, 4
- A61B5/6842
- A01K11/006
- A61B5/117
- A61B5/411
- IPC, 2
- A01K11 00
- A61B5 117
- USPC, 1
- 606117000